Stronger Together

The acquisition of VistaPharm expands PAI Pharma’s product offerings for hospital, retail, and acute care customers. As the industry leader of high-quality, US-made patient centric medicines, we are your partner of choice. We can now offer an even larger portfolio of liquid medications in traditional bottles and unit-dose, all with unmatched commitment to our customers and customer service.

Learn More

New Additions

Our Products

With over 250 product NDCs, PAI Pharma offers the broadest portfolio of unit-dose and liquid medicines. Our products are manufactured in an FDA CGMP-compliant facility and supported by a rigorous quality control process.

Explore Our Portfolio

Latest News

Press Release

PAI Pharma Expands Unit-Dose and Liquid Medicine Offerings by Acquiring VistaPharma

PAI Pharma is pleased to announce the acquisition of VistaPharm—a privately held, healthcare company that offers generic pharmaceuticals and over the counter products for hospitals, retail pharmacies, and the specialized clinical setting. Read More

Press Release

PAI Further Bolsters its Portfolio with the Acquisition of Teligent Sterile Injectable and Topical Products

Pharmaceutical Associates, Inc. (PAI) announces that it has acquired all of the generic and branded US marketing authorizations from Teligent Inc. (Teligent) for an undisclosed amount. Read More

Press Release

Pharmaceutical Associates, Inc. Appoints Dr. Suketu Sanghvi as Chief Scientific Officer

Pharmaceutical Associates, Inc. (PAI) announced today the appointment of Dr. Suketu Sanghvi as Chief Scientific Officer. Read More

Join our Team

As a patient-focused company, our employees are the one that help us make a real difference. Our team is continuously evolving and growing, with opportunities in research and development, sales, marketing, finance, human resources, manufacturing, and technology.

View Openings